Dana Hill

Professor Dana Hill is a distinguished faculty member at the School of Pathology and Immunology at Washington University in St. Louis. With a specialization in the pathology of childhood cancers, she has dedicated her career to advancing the understanding and treatment of these complex diseases. Her work primarily focuses on pleuropulmonary blastoma, Wilms' Tumor, and sarcoma, where she has made significant contributions to the field. Professor Hill's research is particularly noted for its exploration of autoantibody signatures associated with COVID-19 severity and outcomes in children with pleuropulmonary blastoma. This innovative research is paving the way for new insights into how these autoantibodies can influence disease progression and patient outcomes, potentially leading to more effective treatments and interventions. In addition to her research on autoantibodies, Professor Hill is deeply involved in the study of neoplasms, registries, and pediatrics. Her work in these areas has been instrumental in developing comprehensive registries that track the incidence and outcomes of childhood cancers, providing invaluable data for researchers and clinicians alike. Professor Hill's dedication to her field is evident in her commitment to improving the lives of children affected by cancer. Her expertise in Wilms' Tumor and other childhood neoplasms has not only contributed to the academic community but also to the practical treatment strategies employed in clinical settings. Through her research and teaching, she continues to inspire the next generation of medical professionals and researchers in the fight against childhood cancers.